Pancreatic Cancer Research

ResearcherUniversity of Wisconsin–MadisonActive in the last 2 years

Ryan K. Schmocker

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7847-9099; OpenAlex author ID A5086203747. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
54
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 3 papers · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 6

  1. Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: a multinational analysis. Co-author DOI 10.1093/jnci/djag235↗
  2. FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analy… Co-author DOI 10.1245/s10434-023-13353-2↗
  3. Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy. Co-author DOI 10.1016/j.jamcollsurg.2020.11.018↗
  4. Neoadjuvant Treatment and Surgical Resection Are Associated with Survival in Pancreatic Cancer. First author DOI 10.1016/j.jamcollsurg.2021.02.006↗
  5. An Aggressive Approach to Locally Confined Pancreatic Cancer: Defining Surgical and Oncologic Outcomes Unique to Pancreatectomy with Celiac Axis Resection (DP-… Co-author DOI 10.1245/s10434-020-09201-2↗
  6. Utilization of preoperative endoscopic ultrasound for pancreatic adenocarcinoma. Co-author DOI 10.1016/j.hpb.2017.01.017↗

Closest collaborators

The 25 strongest of 54 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jin Peng He · 5 shared papers, 2021–2026 · strength 0.84
  2. Giuseppe Malleo · 2 shared papers, 2023–2026 · strength 0.31
  3. Gregory C. Wilson · 2 shared papers, 2023–2026 · strength 0.31
  4. Russell F. Palm · 2 shared papers, 2023–2026 · strength 0.31
  5. Dilmurodjon Eshmuminov · 2 shared papers, 2023–2026 · strength 0.31
  6. Víctor López‐López · 2 shared papers, 2023–2026 · strength 0.31
  7. Elena B. Rangelova · 2 shared papers, 2023–2026 · strength 0.31
  8. Sarah E. Hoffe · 2 shared papers, 2023–2026 · strength 0.31
  9. Sameer H. Patel · 2 shared papers, 2023–2026 · strength 0.31
  10. Changhoon Yoo · 2 shared papers, 2023–2026 · strength 0.31
  11. Ding Ding · 2 shared papers, 2021 · strength 0.25
  12. William R. Burns · 2 shared papers, 2021 · strength 0.25
  13. Kelly J. Lafaro · 2 shared papers, 2021 · strength 0.25
  14. Michael J. Wright · 2 shared papers, 2021 · strength 0.25
  15. Christopher Lee Wolfgang · 2 shared papers, 2021 · strength 0.25
  16. Syed A. Ahmad · 1 shared paper, 2026 · strength 0.19
  17. José Oberholzer · 1 shared paper, 2026 · strength 0.19
  18. Ning Pu · 1 shared paper, 2026 · strength 0.19
  19. Liang Liu · 1 shared paper, 2026 · strength 0.19
  20. Patricia Sánchez‐Velázquez · 1 shared paper, 2026 · strength 0.19
  21. Michael C. Frey · 1 shared paper, 2026 · strength 0.19
  22. Benedetto Ielpo · 1 shared paper, 2026 · strength 0.19
  23. So Heun Lee · 1 shared paper, 2026 · strength 0.19
  24. Gabriella Lionetto · 1 shared paper, 2026 · strength 0.19
  25. Timothy Michael Pawlik · 1 shared paper, 2026 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.